In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.

about

In vitro antimicrobial susceptibility of clinical isolates of Borrelia miyamotoi.

P2860

Q53694864-C12CEB0D-247B-46AB-97F6-7B8A5B30D239

P2860

In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.

Item

http://www.wikidata.org/entity/Q38695328

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

In Vitro Susceptibility of the ...... motoi to Antimicrobial Agents.

@en

type

Item

label

In Vitro Susceptibility of the ...... motoi to Antimicrobial Agents.

@en

prefLabel

In Vitro Susceptibility of the ...... motoi to Antimicrobial Agents.

@en

P1476

In Vitro Susceptibility of the ...... amotoi to Antimicrobial Agents

@en

P2093

Alex Wagemakers

http://www.w3.org/2001/XMLSchema#string

Anneke Oei

http://www.w3.org/2001/XMLSchema#string

Annemijn Manger

http://www.w3.org/2001/XMLSchema#string

Caroline E Visser

http://www.w3.org/2001/XMLSchema#string

Joppe W Hovius

http://www.w3.org/2001/XMLSchema#string

Ronald O P Draga

http://www.w3.org/2001/XMLSchema#string

P2860

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease

Borrelia miyamotoi Disease in the Northeastern United States: A Case Series.

Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient

Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species.

Human infections with Borrelia miyamotoi, Japan.

Tick surveillance for relapsing fever spirochete Borrelia miyamotoi in Hokkaido, Japan.

Prevalence of Borrelia miyamotoi in Ixodes ticks in Europe and the United States

The relapsing fever spirochete Borrelia miyamotoi is cultivable in a modified Kelly-Pettenkofer medium, and is resistant to human complement.

Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease.

P31

scholarly article

P356

10.1128/AAC.00535-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joris Koetsveld

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28674060

http://www.w3.org/2001/XMLSchema#string

P932

5571331

http://www.w3.org/2001/XMLSchema#string

In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.

about

P2860

P2860

In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932